Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

The Pathologist / Issues / 2021 / Nov / Building Bridges in the Lab
Technology and innovation Software and hardware Insights

Building Bridges in the Lab

Sakura Finetek Europe launches Sakura Bridge, a customized implementation consultancy service that connects professionals and technology

11/02/2021 Longer Read (pre 2022) 1 min read

Share

Building on the prolonged success of SMART Automation, Sakura Finetek Europe continues to innovate with the launch of Bridge – a new implementation consultancy service that connects professionals in the laboratory with Sakura’s technology. By supporting all aspects of innovation in a laboratory, Sakura enables labs to reach their goals, achieve optimal results, and maximize the use of applied Sakura SMART Automation technology in the shortest time possible.

The human aspect is vital

Wilco Alblas, Vice President Customer Operations at Sakura Finetek Europe, comments, “After years of implementing instruments, Sakura gained the knowledge, tools, and resources to realize histopathology laboratories’ visions. We understand that the human aspect is vital in bringing the laboratory into the future. No two labs are the same. Our team of experts guides transitions with the proven Sakura Bridge methodology, placing the key focus on lab staff.”

“Implementing a continuous flow in a laboratory can be challenging – and that human aspect is vital. You must change your processes to get the results you desire. As a company, we have committed to achieving your laboratory’s goals with you. With Sakura Bridge, we take over the challenging aspects of change and ensure optimal results for both technology and people.”

The feeling of empowerment

Bridge, our new implementation consultancy service, empowers you and your team to achieve your objectives. We want you to get the most out of your Sakura technology so that you can produce the best possible results every day.

We believe that implementing new instruments is more about the professionals involved than about bringing in the actual technology. Technology will always be a means to an end – and the reason for its implementation should come from the heart.

We want to help you:

  • Achieve your goals.

Every laboratory has unique goals. With Bridge, we create optimal circumstances for your team to achieve those goals, providing a clear roadmap and implementation plan.

  • Achieve optimal lab results.

You need optimal results to provide optimal service. This is essential for not only your team, but also your patients. Bridge empowers you to provide optimal laboratory results so you can diagnose patients like never before.

  • Maximize utilization.

We want you and your new instrument to work as though you’ve been together for a decade – and maximizing utilization is vital. Bridge provides top-quality results to the laboratory and your team right from the start.

In safe hands

Our team of experts will lead you through your transition with our proven Bridge methodology. What does that mean?

  • Change management
  • Workflow optimization
  • Education and training
  • Technical support
  • Project management

Sakura has the knowledge, tools, and resources to empower you to realize your vision.

More about Sakura Finetek Europe

When it comes to diagnosing cancer, there’s no time to wait. At Sakura Finetek Europe, our drive is our desire to advance cancer diagnosis through fully automated anatomic pathology. We advance cancer diagnostics by providing integrated solutions for anatomic pathology and patients through best-in-class innovations, quality, and customer care. Sakura is the original manufacturer of Tissue-Tek®, Cyto-Tek®, Tissue-Tek VIP®, and Tissue-Tek Xpress®– today’s industry standards. With headquarters based in Alphen aan den Rijn and seven regional locations in Europe, we empower pathology professionals in the EMEAI region to deliver fast, accurate diagnoses to optimize treatment success for each life we touch. Service Sakura Bridge is directly available via your local Sakura contact point.

For more information, go to sakura.eu/bridge, follow us on LinkedIn, or contact us at communication@sakura.eu.

Newsletters

Receive the latest pathology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

Breathing New Life into Diagnostics
Technology and innovation
Breathing New Life into Diagnostics

January 22, 2024

6 min read

Jonathan Edgeworth on how metagenomics could transform testing for respiratory infections

Opening a Window into Brain Trauma
Technology and innovation
Opening a Window into Brain Trauma

January 18, 2024

4 min read

Raman spectroscopy shows promise as the first point-of-care diagnostic device for TBI

Molecular Spectacular
Technology and innovation
Molecular Spectacular

January 8, 2024

1 min read

A look at last year’s most interesting molecular pathology stories

Cracking Colon Cancer
Technology and innovation
Cracking Colon Cancer

January 25, 2024

1 min read

How a new clinically approved AI-based tool enables rapid microsatellite instability detection

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.